Delta-Fly Pharma (TSE:4598) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma COGS-to-Revenue?

Delta-Fly Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was 円0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was 円0.00 Mil.

Delta-Fly Pharma's COGS to Revenue for the three months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Delta-Fly Pharma's Gross Margin % for the three months ended in Dec. 2023 was N/A%.

Delta-Fly Pharma COGS-to-Revenue Historical Data

The historical data trend for Delta-Fly Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma COGS-to-Revenue Chart

Delta-Fly Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

Get a 7-Day Free Trial

Delta-Fly Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Delta-Fly Pharma COGS-to-Revenue Calculation

Delta-Fly Pharma's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Delta-Fly Pharma's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Delta-Fly Pharma (TSE:4598) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Delta-Fly Pharma's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Delta-Fly Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta-Fly Pharma (TSE:4598) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116

Website

http://www.delta-flypharma.co.jp

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines